0.98
-0.045(-4.41%)
Currency In USD
| Previous Close | 1.02 |
| Open | 1.02 |
| Day High | 1.02 |
| Day Low | 0.97 |
| 52-Week High | 9.55 |
| 52-Week Low | 0.69 |
| Volume | 109,624 |
| Average Volume | 266,326 |
| Market Cap | 15.01M |
| PE | 1.91 |
| EPS | 0.51 |
| Moving Average 50 Days | 1.58 |
| Moving Average 200 Days | 2.92 |
| Change | -0.05 |
Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock
GlobeNewswire Inc.
Aug 14, 2025 1:00 PM GMT
Commack, NY, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Scienture Holdings, Inc. (Nasdaq: SCNX) (“Scienture” or the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, ph
SCIENTURE announces the shipment of launch quantities of Arbli™ (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones.
GlobeNewswire Inc.
Aug 13, 2025 12:05 PM GMT
COMMACK, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through
Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding
GlobeNewswire Inc.
Jul 24, 2025 9:12 PM GMT
Commack, NY, July 24, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and car